Clinical trial
Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With…
NCT00085163 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00085163 |
|---|---|
| Title | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon |
| Official title | Multicenter, Double-Blind, Placebo-Controlled Randomized Phase III Study of Adjuvant Therapy With Celecoxib in Combination With Chemotherapy in Patients With Curatively Resected Stage III Colon Cancer |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Collaborators | Dutch Colorectal Cancer Group (DCCG) Arbeitsgemeinschaft fur Internistische Onkologie Onkologie Egyptian Foundation For Cancer Research EORTC GI Group (EORTC 40023) Federation Francophone de… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | celecoxib, fluorouracil, leucovorin calcium, adjuvant therapy |
| Start date | Mar 1, 2004 |
| Primary completion | Nov 1, 2005 |
| First posted | Jun 11, 2004 |
| Last update posted | Oct 20, 2015 |
| Countries | Austria, Belgium, Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: